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Abstract
Background: Tuberculosis (TB) prevalence is closely associated with poverty in China, and poor patients face more
barriers to treatment. Using an insurance-based approach, the China-Gates TB program Phase II was implemented
between 2012 and 2014 in three cities in China to improve access to TB care and reduce the financial burden on
patients, particularly among the poor. This study aims to assess the program effects on service use, and its equity
impact across different income groups.
Methods: Data from 788 and 775 patients at baseline and final evaluation were available for analysis respectively.
Inpatient and outpatient service utilization, treatment adherence, and patient satisfaction were assessed before and
after the program, across different income groups (extreme poverty, moderate poverty and non-poverty), and in
various program cities, using descriptive statistics and multi-variate regression models. Key stakeholder interviews
were conducted to qualitatively evaluate program implementation and impacts.
Results: After program implementation, the hospital admission rate increased more for the extreme poverty group
(48.5 to 70.7%) and moderate poverty group (45.0 to 68.1%), compared to the non-poverty group (52.9 to 64.3%).
The largest increase in the number of outpatient visits was also for the extreme poverty group (4.6 to 5.7). The
proportion of patients with good medication adherence increased by 15 percentage points in the extreme poverty
group and by ten percentage points in the other groups. Satisfaction rates were high in all groups. Qualitative
feedback from stakeholders also suggested that increased reimbursement rates, easier reimbursement procedures,
and allowance improved patients’ service utilization. Implementation of case-based payment made service
provision more compliant to clinical pathways.
Conclusion: Patients in extreme or moderate poverty benefited more from the program compared to a non-poverty
group, indicating improved equity in TB service access. The pro-poor design of the program provides important
lessons to other TB programs in China and other countries to better address TB care for the poor.
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Background
Tuberculosis (TB) prevalence is closely associated with
poverty in China. The 2010 National Tuberculosis
Prevalence Survey shows that TB prevalence is much
higher in rural areas than urban areas (163 vs 73 per
100 000), and higher in the less developed western
region than the developed eastern region (212 vs 66 per
100 000) [1]. Some 83% of TB patients live in households
with incomes below the regional median, and the aver-
age per capita household income of rural TB patients is
50% less than the local regional median [2].
Low-income TB patients in China face greater financial
barriers to quality treatment and have lower treatment
adherence [3, 4]. Currently, TB treatment guidelines by
the World Health Organization (WHO) and Chinese
Center for Disease Control and Prevention (China CDC)
recommend that rifampicin-sensitive newly diagnosed TB
patients should receive 6months of outpatient treatment
and relapse TB patients 8 months [5–7]. A national survey
in 2010 indicated that 10% of TB patients had intermittent
treatment, and another 22% terminated before completing
treatment. 15% of patients who terminated treatment
reported that financial difficulties were the cause for their
poor adherence [1]. TB patients with lower household
incomes and education levels were more likely to report
non-compliance [3]. Since 1990s, first-line anti-TB drugs
and basic diagnostic tests during the standard treatment
course are provided free of charge [8]. However, the
overall cost of TB treatment is substantial, and poor TB
patients are more likely to have catastrophic health
expenditure. A study in three cities in China found that
over 94% of households in the poorest quintile, compared
to 43% in the richest quintile, had catastrophic expen-
diture due to TB treatment [4].
Several factors add to the financial barriers for poor
patients to access TB treatment. First, many poor
patients are covered by the New Rural Cooperative
Medical Scheme (NCMS) or Urban Resident Basic
Medical Insurance (URBMI), which have less compre-
hensive coverage and lower reimbursement rates for TB
services compared to the Urban Employee Basic Medical
Insurance (UEBMI) [9]. Second, low-income rural TB
patients more often go to smaller regional hospitals that
have a lower capacity to diagnose and treat complex
cases. This may lead to over-provision of unnecessary
and often expensive services not covered by the govern-
ment free treatment policy or health insurance, such as
computed tomography (CT) scans, branded second-line
anti-TB drugs, liver protection and other ancillary drugs,
the cost of which may further deter poor patients from
completing treatment [10]. In addition, many poor
patients live in rural and remote areas. Seeking treatment
may therefore require travelling a considerable distance,
incurring substantial transportation and accommodation
costs [10] and possible loss of income.
To improve access to TB care and reduce the financial
burden, particularly in rural areas, the China-Gates TB
program Phase II was implemented between 2012 and
2014 in three prefectures from eastern (Zhenjiang), central
(Yichang) and western (Hanzhong) China. The program
context and intervention details have been documented
elsewhere [8]. Briefly, the new TB financing and payment
model includes: 1) increasing health insurance reimburse
rates for hospitalization and outpatient TB services to
70%; 2) changing the provider payment method to case-
based payment from the current fee-for-service, to
incentivize cost containment by TB-designated hospitals.
For practical reasons, the case-based payment design
included distinct payment packages for inpatient and out-
patient services; 3) providing transportation and sub-
sistence allowances to TB patients who adhered to
treatment (including those without health insurance).
Equity assessment at study baseline revealed that rural
residents in project counties had less service utilization,
but more out-of-pocket payment per hospital admission
compared to urban employees and urban residents [11].
Analysis of the rural TB patients enrolled in the NCMS
also revealed low reimbursement rate and high financial
risk [12]. Service access and financial risk protection for
TB patients with lower socioeconomic status were iden-
tified as major gaps in TB care [8].
There is rich international literature suggesting that pub-
lic subsidies for health programs frequently benefit richer
more than poorer people [13, 14]. Whether a health
insurance-based approach can effectively target the poor
and improve equity is therefore of great concern. This study
aims to address this issue by considering the impact of the
China-Gates TB program (Phase II) on service utilization,
treatment adherence and patient satisfaction across three
income groups identified as consisting of those living in: ex-
treme poverty, moderate poverty and non-poverty.
Methods
Study setting
Quantitative data were obtained from cross-sectional sur-
veys with TB patients at the baseline of the program in
2012 and final evaluation in 2014. Three counties (one
low-income, one middle-income and one high-income)
were selected in each of the three project prefectures
(Zhenjiang, Yichang and Hanzhong). In each of the above
9 counties, TB patients who had been diagnosed for more
than 6 months (8 months for relapse patients) were identi-
fied from the China CDC‘s TB information management
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system (TBIMS), which is a national registry for the com-
pulsory reporting and management of confirmed TB
cases. Ninety TB patients were randomly sampled
from each of the nine counties’ TBIMS. When less
than 90 patients were present in a county, all patients
were sampled. One of the county was excluded from ana-
lysis due to an unexpected restructuring of regional TB
management system, leading to incomparable data at
baseline and final evaluation. Face-to-face interviews were
conducted using a structured questionnaire, which in-
cluded information on patient socio-economic back-
ground, treatment history, and satisfaction. A total of 788
patient questionnaires were analysed from the baseline
survey and 775 from the final evaluation survey.
Income grouping and poverty status
The self-reported per capita annual income of a patient’s
household was used for income grouping. Following the
World Bank’s definition of extreme poverty globally and
the poverty line for upper-middle income countries,
those with incomes less than USD 1.9 a day (RMB 4369
per annum) were classified as being in extreme poverty,
those with incomes between USD 1.9 to 5.5 a day (RMB
12647 per annual) were classified as being in moderate
poverty, and the rest were classified as non-poverty
households [15]. This classification was validated to be
relevant to local poverty standards in Zhenjiang, Yichang
and Hanzhong. The local living assistance standards for
urban residents announced by the Department of Civil
Affairs all three cities in 2014 were similar to or higher
than the World Bank standard of extreme poverty.
Measuring service utilization, adherence, and patient’s
satisfaction
Inpatient and outpatient service utilization indicators
were analysed, including the hospital admission rate,
average number of hospital admissions per patient, rate
of hospital re-admission within 3 days of discharge,
average length of stay for the first admission, and
average number of outpatient visits during a treat-
ment course (6 months for new patients, and 8 months
for relapse patients). Medication adherence was charac-
terized using the following indicators: proportion of
patients refusing treatment, taking medications as pre-
scribed, and terminating treatment. Patient satisfaction
was measured relating to: treatment outcome, reimburse-
ment rate, reimbursement procedures, attitudes of doctors
and nurses.
Statistical analysis
Utilization of inpatient and outpatient services, patient
adherence and satisfaction were examined for each
poverty status at baseline and at final evaluation using
descriptive statistics.
The effect of the program on the rate of hospital
admission, rate of re-admission within 3 days after dis-
charge, and proportion of patients with good medication
adherence were analysed using multivariate logistic
regression model. Number of outpatient visits over the
whole treatment course were analysed using Poisson
regression. All regression models included the following
explanatory variables: period (baseline, final evaluation),
poverty status and the interaction term between poverty
status and period as explanatory variables. All models
were controlled for county fixed effects and cluster-
robust standard errors were used for statistical testing. A
set of control variables were included in all regression
models, including gender, age, marital status, TB type
(new, relapse), education level, employment status and
health insurance type. The models estimated were thus
of the form:
Outcome = f (poverty status, period, poverty status*-
period, control variables, county fixed effect).
All analyses were performed using Stata 14 (Version
14, StataCorp, College Station, TX. Statistical signifi-
cance were assessed at P = 0.05.
Qualitative interviews and analyses
Qualitative data were obtained during the final evaluation
period of the program in 2014. Semi-structured in-depth
interviews were conducted with city- and county-level
health administrators (n = 12), health insurance managers
(n = 20) and hospital managers (n = 12) to understand
their perceptions of the program impacts on poor TB
patients’ service utilization and equity. Two focus group
discussions (FGDs) were held with healthcare providers in
TB designated hospital and primary care doctors in each
study county to explore their views of the program
impacts on service provision and patient adherence. Each
group consisted of 5–6 physicians and nurses who pro-
vided outpatient and/or inpatient TB care and were
responsible for TB patient management. In addition, two
FGDs with TB patients were organized in each study
county to gain understandings of patients’ care seeking
and treatment experiences and level of satisfaction. TB
patients were quota sampled based on their gender,
household income and type of health insurance coverage.
Each group consisted of 6 TB patients and was held in a
private room in the hospital. All interviews were con-
ducted by experienced evaluation team members and
recorded after obtaining the permission of participants.
The Framework approach [16] was used to analyse the
qualitative data. A framework constructed using the
topic guide, field notes and categories emerging from
the transcripts, was applied to the data to identify
themes. Data from different stakeholders and other
sources were triangulated. The key findings were also
validated by external consultation.
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Results
A total of 788 patient questionnaires were analysed from
the baseline survey and 775 from the final evaluation sur-
vey. The socio-economic characteristics of patients were
similar in both samples, except for their health insurance
coverage (Table 1). At baseline, 34% of patients were clas-
sified as in extreme poverty and 42% in moderate poverty
compared to 36 and 40% at final evaluation.
After program implementation, utilization of inpatient
and outpatient services increased, but to different extents
in different poverty groups. The hospital admission rate
increased from 48.1 to 68.1% among all patients, and the
increase was greater for the extreme poverty and mo-
derate poverty groups (Table 2). The average number of
hospital admissions decreased from 1.4 to 1.2, and the rate
of re-admissions decreased from 23.0 to 15.5%. The length
of stay for the first hospital admission increased in the
extreme and moderate poverty groups, but decreased in
the non-poverty group. The number of outpatient visits
increased from 4.8 to 5.7 among all patients, and the
increase was highest in the extreme poverty group.
After program implementation, medication adherence
improved the most in the extreme poverty group
(Table 3). The proportion of patients refusing treatment
decreased in the extreme poverty and non-poverty
groups, but not in the moderate poverty group. The
proportion of patients taking medication on schedule as
prescribed increased by 15 percentage points in the
extreme poverty group, and 10 percentage points in the
other two groups. The proportion terminating treatment
also decreased the most in the extreme poverty group,
followed by the moderate poverty group.
Over 90% of patients reported satisfaction with treat-
ment outcome, procedure, and the attitudes of doctors
and nurses in both baseline and final evaluation surveys,
and the proportion satisfied were slightly higher at final
evaluation compared to baseline (Table 3). Reimburse-
ment rates were satisfactory to the smallest proportion
of patients but were still seen as acceptable to around
87% before and 90% after program implementation. The
satisfaction did not seem to vary by poverty group.
The multivariate regression results are shown in
Table 4. As expected, the overall hospitalization rate was
substantially higher for members of the non-poverty
group (OR = 1.44, P = 0.05). However, while program
implementation appears to have considerably increased
the hospitalization rate for all income groups (OR = 2.83,
P = 0.01), the increase was much lower for the non-
poverty group (OR = 0.56, P = 0.04), indicating increased
equity of access. The re-admission rate did not seem to
change after the program and there were no significant
variations across poverty groups. The number of out-
patient visits increased for all groups, and intra-group
differences were not significant. The proportion of
patients with good medication adherence improved
significantly (OR = 2.88, P = 0.01), and there were again
no significant differences across poverty groups. Patient
satisfaction with treatment outcomes improved after the
program but satisfaction with the reimbursement rate
did not change.
The qualitative results support the quantitative findings
on increased outpatient and inpatient TB service use, and
allow identification of some of the underlying reasons. First,
most health administrators, health insurance managers,








Male 74.8 70.7 0.070
Age (%)
< 30 6.2 7.4 0.070
30–59 46.7 41.0
≥ 60 47.1 51.6
Marriage (%)
Married 80.3 78.2 0.290
Residence (%)
Rural 92.5 90.0 0.083
Patient category (%)
New patient 81.4 82.2 0.670
Education level (%)
None 20.2 25.0 0.052
Primary 32.9 33.6
Secondary 34.0 28.7
High school and above 12.9 12.8
Insurance type (%)




Private insurance 1.8 0.4
other insurance 0.3 0.3






Extreme poverty 34.0 36.1 0.642
Moderate poverty 42.0 40.0
Non-poverty 24.0 23.9
UEBMI Urban employee basic medical insurance, URBMI Urban resident basic
medical insurance, NCMS New corporative medical scheme, URRBMI Urban
rural resident basic medical insurance
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hospital managers and TB care providers thought that the
increased health insurance reimbursement rate for TB care
and the simplified reimbursement procedure for patients
had a positive impact on service use, particularly among
poor TB patients. Several TB care providers explained that
the reimbursement rate for TB outpatient care was low
before the introduction of the program, for example, only
20% of eligible expenditure would be reimbursed by
NCMS, as compared to 80% after program implementation.
Most TB patients also expressed their satisfaction with the
increased reimbursement rate. Second, hospital managers
mentioned that an upgraded IT system for case-based pay-
ment allowed patients to receive insurance reimbursement
at the time of bill payment. Previously, paying a substantial
deposit at admission or paying out-of-pocket while receiv-
ing treatment placed a major burden on poor patients.
Some terminated treatment due to an inability to afford
such payments even though a large proportion was ex-
pected to be reimbursed subsequently by insurance. Third,
patients found transport and subsistence allowances pro-
vided effective motivation to undertake follow-up visits,
especially for poor patients living in remote rural or moun-
tainous areas. Travelling to a hospital could take many
hours and entail significant costs, sometimes requiring an
over-night stay. The allowances partially offset such costs,
and disbursement of a lump sum payment upon com-
pletion incentivized treatment adherence.
The current direct exemption of reimbursable
expenses (at time of bill payment upon discharge)
is good for poor patient, and rich patients may not
care. (TB hospital manager)
Table 2 Inpatient and outpatient service utilization at baseline and final evaluation (by income group)
Indicator Period Extreme poverty Moderate poverty Non-poverty Total
Hospital admission rate (%) Baseline 48.5 45.0 52.9 48.1
Final evaluation 70.7 68.1 64.3 68.1
Average number of hospital admissions Baseline 1.5 1.3 1.3 1.4
Final evaluation 1.3 1.2 1.2 1.2
Average rate of hospital re-admissions (%) Baseline 29.2 17.5 23.0 23.0
Final evaluation 21.2 11.9 12.6 15.5
Average length of stay of the first
admission (days)
Baseline 21.1 22.6 26.1 23.0
Final evaluation 24.0 24.7 25.6 24.7
Average number of outpatient visits during
treatment coursea
Baseline 4.6 5.0 4.8 4.8
Final evaluation 5.7 5.7 5.8 5.7
aOnly patients who had been diagnosed as TB for more than 6/8 months at the time of survey were included for analysis of outpatient visits
Table 3 Program effect on patients’ treatment adherence and satisfaction
Indicator Period Extreme poverty Moderate poverty Non-poverty Total
Proportion of patients who refused
treatment (%)
Baseline 4.9 2.4 2.7 3.3
Final evaluation 2.9 2.9 1.6 2.6
Proportion of patients taking medications
as prescribed (%)
Baseline 75.4 81.6 81.0 79.3
Final evaluation 90.5 93.1 92.3 92.0
Proportion of patients terminating
treatment (%)
Baseline 19.0 13.0 15.9 15.7
Final evaluation 5.9 4.9 6.0 5.5
Proportion of patients who satisfy with
the treatment outcome (%)
Baseline 94.7 92.1 93.1 93.2
Final evaluation 96.8 96.1 98.4 96.9
Proportion of patients who satisfy with
the reimbursement rate (%)
Baseline 86.2 86.9 88.3 87.0
Final evaluation 90.9 89.5 89.0 89.9
Proportion of patients who satisfy with
the reimbursement process (%)
Baseline 93.1 90.5 92.3 91.8
Final evaluation 93.3 90.6 93.3 92.3
Proportion of patients who satisfy with
doctor’s attitude (%)
Baseline 96.1 96.6 99.0 97.1
Final evaluation 99.1 98.2 99.2 98.8
Proportion of patients who satisfy with
nurse’s attitude (%)
Baseline 96.9 97.3 99.0 97.6
Final evaluation 99.1 97.8 98.4 98.4
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I received RMB 180 for transportation and nutrition
allowance. It helps me. Maybe you (policy maker) can
consider giving more for those who live far away. (TB
patient, FGD)
Some hospital managers and providers considered the
design of the health insurance reimbursement package
to be in line with the standard TB clinical treatment
pathway, which to some extent improved quality of TB
care and case management. Several providers said that
after program implementation, they prescribed TB
treatment-related tests according to the clinical guideline
and strengthened coordination with primary healthcare
providers to follow up TB patients and encourage them
to attend scheduled hospital visits. In FGDs with TB
patients, many patients said they had frequent contacts
with healthcare providers.
Before the program, we only did some of the tests (like
liver function test, blood test, kidney function)
Table 4 Program effect for different income groups








Odds ratio P value Odds ratio P value Coefficient P value Odds ratio P value Odds ratio P value
Poverty status (Moderate poverty as
reference group)
Extreme poverty 1.1 0.7 2.2 0.06 −0.1 0.21 0.7 0.23 1.5 0.07
Non-poverty 1.4 0.05 1.5 0.08 −0.1 0.27 0.9 0.55 1.3 0.48
Period (baseline as reference group)
Final evaluation 2.8 0.01 0.6 0.11 0.1 0.01 2.9 0.01 2.0 0.04
Income level* Period
Extreme poverty *Final evaluation 1.0 0.98 1.1 0.9 0.1 0.16 1.1 0.88 0.7 0.44
Non-poverty *Final evaluation 0.6 0.01 0.8 0.46 0.1 0.16 0.9 0.72 2.6 0.16
Gender (male as reference group)
Female 0.7 0.01 1.2 0.46 0.0 0.28 1.1 0.62 1.5 0.16
Age group (< 30 as reference group)
30–59 0.9 0.82 2.7 0.01 0.0 0.46 0.9 0.68 0.8 0.58
60+ 1.2 0.08 1.0 0.83 0.0 0.89 1.0 0.83 1.9 0.08
Type of TB (newly diagnosed as
reference group)
Relapse 1.0 0.76 1.2 0.49 −0.1 0.14 0.6 0.01 0.5 0
Marital status (single as reference group)
Married 1.0 0.89 1.2 0.52 0.1 0.23 1.1 0.56 0.8 0.57
Education (no formal education as
reference group)
Primary 1.0 0.68 0.9 0.68 0.0 0.30 1.0 0.97 1.0 0.95
Secondary 1.1 0.67 1.2 0.46 0.1 0.21 1.2 0.52 1.1 0.87
≥ High school 1.0 0.84 1.2 0.64 0.1 0.16 2.1 0.01 0.5 0.04
Insurance type
UEBMI 0.4 0.04 1.0 0.96 0.0 0.86 1.6 0.17 0.5 0.35
NCMS 0.4 0.01 1.3 0.46 0.0 0.64 1.4 0.38 0.8 0.82
URRBMI 0.3 0 1.4 0.65 0.1 0.06 1.9 0.59
Private 1.1 0.91 0.0 0.84 0.7 0.52
No insurance 0.4 0.06 0.3 0.07 −0.1 0.70 1.3 0.46 0.8 0.85
Other insurance 0.9 0.96 1.8 0.69 0.4 0.01 0.6 0.59
Currently working (currently no
working as reference group)
0.6 0 0.9 0.57 0.0 0.95 0.8 0.33 1.3 0.38
UEBMI Urban employee basic medical insurance, URBMI Urban resident basic medical insurance, NCMS New corporative medical scheme, URRBMI Urban rural
resident basic medical insurance
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occasionally. After patients are discharged, we didn’t
follow them anymore. Now, there is emphasis on
standard treatment and quality, so we have improved
on tests. Those necessary tests are done every month. If
patients have adverse reactions, they can receive
timely treatment. (TB doctor, FGD)
Now after a patient leave the hospital, we inform the
village doctor to supervise the patient, and call the
patient every month to remind him/her of the follow-
up visit. (TB doctor, FGD)
Discussion
Overall, the China-Gates TB program Phase II has
improved inpatient and outpatient TB care access,
reduced re-admissions, enhanced medication adherence,
and improved patient’s satisfaction with treatment out-
comes. It was also found to be pro-poor and to have
improved equity in inpatient TB care access across dif-
ferent poverty groups: the program effects on hospital
admissions were greater for the extreme poverty and
moderate poverty groups, compared to the non-poor
group. Program effects on outpatient service utilization
were similar across different groups, and number of out-
patient visit did not correlate with poverty status.
One commonly suggested potential adverse conse-
quence of case-based payment is that facilities may under-
provide necessary services to control costs [17–19]. On
the contrary, the increased number of outpatient visits
observed in this study and qualitative findings from the
study suggest that patients were in fact better managed,
i.e. more in line with established clinical guidelines. This
was probably mainly because the payment standard for
the outpatient package was generous in terms of covering
the full cost of services and drugs recommended by the
clinical treatment guideline.
While the reduced gap in terms of inpatient service use
between poor and non-poor TB patients indicates im-
proved equity, it remains difficult to assess with existing
data if the high levels of hospitalization following the
intervention implementation represent an improvement
in service provision, as a majority of TB patients may only
require outpatient treatment according to global and
national treatment guidelines. The original case-based
payment design was a standard payment rate for inpatient
and outpatient TB services combined, aiming to promote
substitution of hospitalization by outpatient treatments
and to avoid unnecessary hospitalization. However, during
the program implementation, significant challenges were
encountered from hospitals and health insurance agencies
in program regions due to expected reduction in revenue,
and difficulty in management. As a result, two payment
packages were implemented for inpatient and outpatient
services separately, the design of which was unable to
reduce hospitalization. The detailed implementation
challenges and consequences were discussed in detail in
another paper by the same study team. Nevertheless, the
decreasing gap in inpatient service utilization between the
extreme-poverty group and non-poverty group could have
positive effects, as qualitative interviews revealed that
many extreme-poverty patients were elderly patients and
had several co-morbidities (such as diabetes, hypertension,
and kidney diseases) or side effects from TB treatment.
Better access to inpatient services may improve the
management of complex TB cases with co-morbidities.
Future studies are needed to access the health service
quality and appropriateness, and treatment outcomes.
The pro-poor effects can be explained by several
features. First, the program required reimbursement
rates for all insurance schemes to be no less than
70% for covered inpatient and outpatient services. Before
the program, there was wide variation in reimbursement
rates by the three major health insurance schemes. NCMS
and URBMI reimbursed 60–75% of inpatient expenses,
whereas UEBMI reimbursed 85–95% [11]. NCMS and
URBMI had no or low reimbursement rates for outpatient
expenses [11]. Poor TB patients usually enrol in NCMS
and URBMI schemes which have lower reimbursement
rates. The program reduced the disparity in reimburse-
ment rates, thereby favouring the poor. Second, an
upgraded IT system that allowed immediate insurance
reimbursement was most beneficial for poorer patients, as
they were not required to pay a large amount of cash at
the point of service use, and then got a reimbursement
later. Third, transport and subsistence allowances pro-
vided strong incentives to poor patients, many of whom
live in remote rural areas and had higher transportation
costs, to seek care. Fourth, medical financial assistance
was provided by the Department of Civil Affairs for a rela-
tively small number of eligible low-income households,
further reducing their financial burden. Fifth, from the
supply side, the implementation of case-based payment,
clinical pathways, and case management probably im-
proved the treatment and management quality more in
under-developed areas, where many poor patients resided.
Despite great improvements in TB management, poor
TB patients still face a number of barriers and chal-
lenges in accessing health care and completing treat-
ment. Some TB services and drugs were excluded from
insurance program reimbursement. For example, in
many counties, CT scans, branded liver-protection drugs
and ancillary drugs were not covered by insurance, nor
restricted by the cost limit of case-based payment [6].
Though case-based payment was designed to restrict the
provision of unnecessary tests and drugs, their actual
use was not uncommon. For instance, a significant
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proportion of patients reported having adverse reactions
to free anti-TB drugs, and were therefore given more
expensive second line drugs and in some cases were
encouraged to take liver-protection drugs, or be admit-
ted for inpatient care. In order to further reduce the
financial barriers to care for poor TB patients, the types
of services covered by insurance should be expanded,
with appropriate safeguards to control unnecessary use
of more expensive treatments.
The study was not without limitations. There was very
limited quantitative information on patient case-mix and
service details (such as prescriptions and procedures).
Therefore, appropriateness and quality of services cannot
be assessed objectively. Service quality can only be in-
ferred from reported patient satisfaction and qualitative
feedback from patients, doctors and administrators.
Besides, the program consists of multiple concurrent
interventions that may be synergistic or antagonistic, and
thus the effects of each individual intervention cannot be
evaluated separately.
Conclusions
The China-Gates TB program Phase II effectively im-
proved TB patients’ access to inpatient and outpatient
services and improved medication adherence across all
income groups. Patients in households classified as in
extreme or moderate poverty benefited more from the
inpatient service coverage of the program compared
to a non-poverty group, indicating improved equity in
inpatient TB service access. The pro-poor design of
the program provides important lessons to other TB pro-
grams in China and other countries to better address TB
care for the poor. The study also identified other
difficulties poor TB patients face that need to be fur-
ther addressed.
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